At a healthcare conference in San Francisco, Illumina announced that it has developed a DNA sequences machine capable of decoding five complete genomes per day. ILMN CEO Jay Flatley told the conference that the HiSeq X Ten machines could scan …
Investor Place · ByChristopher Freeburn · 1/16/2014
Illumina, Inc. (NASDAQ:ILMN) is the most popular stock in this table with 62 long positions, while Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX), even though it is not the most popular stock in this group, it …
INSIDER MONKEY · 11/24/2015
Vertex Pharmaceuticals Incorpo…
Illumina, Inc. (NASDAQ:ILMN) stock continues to gain value today, after the update that it will replace Sigma-Aldrich Corporation (NASDAQ:SIAL) in the S&P 500 Index, effective from Wednesday’s close of trade. The … · 11/16/2015
Sigma Aldrich
In-depth coverage >
Illumina will be in the S&P 500 Index Illumina (ILMN) rose by 2.7% on November 16, 2015. It rose for the fourth consecutive trading session. Illumina rose 10% in the trailing five-day period. The stock rose due to its inclusion in the S&P 500 Index.
Market Realist · 11/17/2015
ILMN). InvestorsObserver's PriceWatch Alerts contain concise, detailed strategies for each stock we cover, including position protection tactics designed to defend investors from potential market shifts. While many other market reports only provide stock ...
The Business Journal · 11/18/2015
Weight Watchers
BTIG downgraded Illumina (NASDAQ: ILMN) from Buy to Neutral ... but our revised 2016 forecasts are not currently supportive of a high-growth multiple for the stock." For an analyst ratings summary and ratings history on Illumina click here.
StreetInsider · 10/6/2015
Gene-sequencing giant Illumina (NASDAQ:ILMN) pre-announced Q3 revenue and full-year guidance that missed estimates Monday, sending its stock tumbling after hours. Illumina said Q3 revenue totaled $550 million, up 14% from the year-earlier quarter but …
Investors Business Daily · ByAmy Reeves · 10/5/2015
Mizuho cut shares of Illumina (NASDAQ:ILMN) from a buy rating to a neutral rating in a research note issued to investors on Tuesday, The Fly reports. The brokerage currently has $150.00 price target on the life sciences company’s stock, down from their ...
Mideast Times · 10/12/2015
Welcome to Schaeffer's Investment Research! We are a privately held provider of stock and options trading recommendations, options education, and market commentary, headquartered in Cincinnati, Ohio. Founded in …
Schaeffer's Investment Research · 11/13/2015
Mylan NV
Illumina (ILMN) has been a red hot stock of late, riding momentum to new all time highs this week. But we should learn a lot more about the recent price action when Illumina reports earnings after the market close today. According to estimize, analysts ... · 7/21/2015


Illumina, Inc. is an American company incorporated in April 1998 that develops, manufactures and markets integrated systems for th…
Illumina, Inc. is an American company incorporated in April 1998 that develops, manufactures and markets integrated systems for the analysis of genetic variation and biological function. In 2014, Illumina was named the world's smartest company by MIT Technology Review. Using its technologies, the company provides a line of products and services that serve the sequencing, genotyping and gene expression markets. This technology had purportedly by 2013 reduced the cost of sequencing a human genome to US$4,000, down from a price of US$1 million in 2007. Customers include genomic research centers, pharmaceutical companies, academic institutions, clinical research organizations and biotechnology companies. Its tools provide researchers with the capability to perform genetic tests needed to extract medical information from advances in genomics and proteomics. Its headquarters are located in San Diego, California.
Data from: Wikipedia